NF2

Clinical trials for NF2 explained in plain language.

Never miss a new study

Get alerted when new NF2 trials appear

Sign up with your email to follow new studies for NF2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for NF2: experimental drug aims to shrink tumors and save hearing

Disease control Not yet recruiting

This early-stage trial tests a daily drug called PRG-N-01 in 25 adults with neurofibromatosis type II (NF2), a genetic condition that causes non-cancerous tumors on nerves, often leading to hearing loss. The study aims to find the safest and most effective dose, and to see if the…

Matched conditions: NF2

Phase: PHASE1, PHASE2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control

Last updated May 12, 2026 13:43 UTC

NF2

Get alerted when new NF2 trials appear

New hope for NF2: experimental drug aims to shrink tumors and save hearing